Jane J. Zara

Array ( [id] => 6705823 [patent_doc_number] => 20030152557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Methods for inhibiting histone deacetylase-4' [patent_app_type] => new [patent_app_number] => 10/051819 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20216 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152557.pdf [firstpage_image] =>[orig_patent_app_number] => 10051819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6558428 [patent_doc_number] => 20020164579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Prevention of cell migration initiation with CMV US28 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/044070 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 3793 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164579.pdf [firstpage_image] =>[orig_patent_app_number] => 10044070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751174 [patent_doc_number] => 20030045695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Ribozyme for detecting gene sequence' [patent_app_type] => new [patent_app_number] => 10/032794 [patent_app_country] => US [patent_app_date] => 2001-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11606 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045695.pdf [firstpage_image] =>[orig_patent_app_number] => 10032794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852021 [patent_doc_number] => 20030144224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antisense modulation of B-cell associated protein expression' [patent_app_type] => new [patent_app_number] => 10/020478 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25718 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144224.pdf [firstpage_image] =>[orig_patent_app_number] => 10020478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740229 [patent_doc_number] => 20030157598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney' [patent_app_type] => new [patent_app_number] => 10/010568 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 134250 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157598.pdf [firstpage_image] =>[orig_patent_app_number] => 10010568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683903 [patent_doc_number] => 20030119767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antisense modulation of NOD1 expression' [patent_app_type] => new [patent_app_number] => 10/006883 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119767.pdf [firstpage_image] =>[orig_patent_app_number] => 10006883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1089000 [patent_doc_number] => 06828151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Antisense modulation of hematopoietic cell protein tyrosine kinase expression' [patent_app_type] => B2 [patent_app_number] => 10/007010 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31228 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828151.pdf [firstpage_image] =>[orig_patent_app_number] => 10007010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473166 [patent_doc_number] => 20020151491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Composition and method for treating the over-production of mucin in diseases such as otitis media using an inhibitor of MUC5AC' [patent_app_type] => new [patent_app_number] => 09/997551 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10140 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151491.pdf [firstpage_image] =>[orig_patent_app_number] => 09997551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761915 [patent_doc_number] => 20030125277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Antisense modulation of activating transcription factor 3 expression' [patent_app_type] => new [patent_app_number] => 10/010002 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25758 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125277.pdf [firstpage_image] =>[orig_patent_app_number] => 10010002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761911 [patent_doc_number] => 20030125273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Antisense modulation of MHC class II transactivator expression' [patent_app_type] => new [patent_app_number] => 10/006366 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125273.pdf [firstpage_image] =>[orig_patent_app_number] => 10006366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625831 [patent_doc_number] => 20020086321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Myeloid cell leukemia associated gene MCL-1' [patent_app_type] => new [patent_app_number] => 10/007573 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12784 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086321.pdf [firstpage_image] =>[orig_patent_app_number] => 10007573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874544 [patent_doc_number] => 20020049154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Bioconjugates and delivery of bioactive agents' [patent_app_type] => new [patent_app_number] => 09/982968 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21217 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049154.pdf [firstpage_image] =>[orig_patent_app_number] => 09982968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1126874 [patent_doc_number] => 06790827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-14 [patent_title] => 'Bioconjugates and delivery of bioactive agents' [patent_app_type] => B2 [patent_app_number] => 09/982940 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 21041 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790827.pdf [firstpage_image] =>[orig_patent_app_number] => 09982940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139549 [patent_doc_number] => 06776976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-17 [patent_title] => 'Bioconjugates and delivery of bioactive agents' [patent_app_type] => B2 [patent_app_number] => 09/982892 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 21045 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/776/06776976.pdf [firstpage_image] =>[orig_patent_app_number] => 09982892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062921 [patent_doc_number] => 06849612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Oligonucleotide modulation of cell adhesion' [patent_app_type] => utility [patent_app_number] => 09/982262 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 16078 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849612.pdf [firstpage_image] =>[orig_patent_app_number] => 09982262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735460 [patent_doc_number] => 20030013095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Nucleic acid enzymes acquiring an activity for cleaving a target RNA by recognizing another molecule' [patent_app_type] => new [patent_app_number] => 09/974974 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8855 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013095.pdf [firstpage_image] =>[orig_patent_app_number] => 09974974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1171857 [patent_doc_number] => 06750019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Antisense modulation of insulin-like growth factor binding protein 5 expression' [patent_app_type] => B2 [patent_app_number] => 09/975123 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27925 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750019.pdf [firstpage_image] =>[orig_patent_app_number] => 09975123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016927 [patent_doc_number] => 20020103154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs' [patent_app_type] => new [patent_app_number] => 09/965602 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 28962 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103154.pdf [firstpage_image] =>[orig_patent_app_number] => 09965602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340673 [patent_doc_number] => 20020034505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor' [patent_app_type] => new [patent_app_number] => 09/962489 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8350 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034505.pdf [firstpage_image] =>[orig_patent_app_number] => 09962489 [rel_patent_id] =>[rel_patent_doc_number] =>)